Impact of Reduced Fluoroquinolone Use on Clostridioides difficile Infections Resulting From the Fluoroquinolone-Resistant Ribotype 027 Strain in a Veterans Affairs Medical Center | Zendy

Sarah N. Redmond | Zendy; Sandra Y. Silva | Zendy; Brigid Wilson | Zendy; Jennifer L. Cadnum | Zendy; Curtis J. Donskey | Zendy

Open Access

Impact of Reduced Fluoroquinolone Use on Clostridioides difficile Infections Resulting From the Fluoroquinolone-Resistant Ribotype 027 Strain in a Veterans Affairs Medical Center

Author(s) -

Sarah N. Redmond,

Sandra Y. Silva,

Brigid Wilson,

Jennifer L. Cadnum,

Curtis J. Donskey

Publication year - 2019

Publication title -

pathogens and immunity

Language(s) - English

Resource type - Journals

ISSN - 2469-2964

DOI - 10.20411/pai.v4i2.327

Subject(s) - clostridioides , veterans affairs , strain (injury) , clostridium difficile , medicine , microbiology and biotechnology , biology , antibiotics

Fluoroquinolone restriction has been proposed as a control measure for Clostridioides difficile infection (CDI) outbreaks associated with fluoroquinolone-resistant ribotype 027 strains. However, relatively few reports of fluoroquinolone restriction interventions have evaluated the impact on C. difficile strain types and fluoroquinolone resistance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research